ArticleWorld journal of hepatology2025
Sex, racial, and ethnic disparities in United States liver transplantation clinical trials.
Article in World journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRegulatory agencies are increasingly recognizing that minority trial representation is inadequate, contributing to healthcare disparities. The scope of minority population disparities in clinical trial participation remains unclear, as previous studies have compiled enrollment data from published trials, which frequently do not report participant race and ethnicity.
aimTo evaluate sex, racial and ethnic inequities in liver transplantation (LT) trials participation in the United States.
methodsWe used data from completed United States liver transplant clinical trials registered and reported on the National Institute of Health (NIH) website (clincaltrials.gov). Demographic data, including race, ethnicity, sex, and age were collected. To make inferences to a larger population, 95%CIs were computed for estimates in each demographic group using the Wilson method for binomial proportions. We also computed the simultaneous 95%CIs by applying a Bonferroni correction to reflect the multinomial distribution of race proportions. The numbers and percentages of racial/ethnic minority and female individuals compared with United States census data from 2010 and 2018. Secondary outcome measures were inclusion by trial funding source and year of completion.
resultsA total of 69 United States based clinical trials involving 6990 participants were included in the analysis. Of these, 35 trials (51%) were randomized, and 26 (38%) were conducted across multiple United States regions. All trials reported sex, while 42 (61%) reported race and 27 (39%) reported ethnicity. Compared to United States census data, Asian individuals were overrepresented (9.3%; 95%CI: 8.1%-10.5%), whereas African American (7.8%; 95%CI: 6.7%-8.9%) and American Indian or Alaska Native individuals (0.4%; 95%CI: 0.1%-0.6%) were underrepresented. The proportion of White participants (75.9%; 95%CI: 74.1%-77.7%) was consistent with census estimates. Hispanic participants were underrepresented (13.3%; 95%CI: 12.2%-14.5%) regardless of the census year referenced. In industry-sponsored trials, Asian representation was three times higher than in the general population (15%). NIH funded trials showed overrepresentation of White participants (83.8%) and underrepresentation of Black participants (4.1%) relative to census data. Women comprised 31.1% of all participants (95%CI: 30.0%-32.2%), indicating underrepresentation. Among trials that reported racial data, 62 (90%) did not include participants of American Indian or Alaska Native, Native Hawaiian, or Pacific Islander descent.
conclusionOur analysis indicates that women, African Americans, and Hispanic individuals are underrepresented in LT clinical trials compared to the general United States population. These results highlight the need for regulatory initiatives aimed at enhancing the inclusion of historically marginalized racial and ethnic groups in clinical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.